Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13 » default

ClinicoEconomics and Outcomes Research


Archive: Volume 13, 2021

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

ClinicoEconomics and Outcomes Research 2021, 13:263-277

Published Date: 22 April 2021

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan

Tokunaga K, Suzuki C, Hasegawa M, Fujimori I

ClinicoEconomics and Outcomes Research 2021, 13:241-250

Published Date: 16 April 2021

Factors and Economic Outcomes Associated with Documented Difficult Intubation in the United States

Moucharite MA, Zhang J, Giffin R

ClinicoEconomics and Outcomes Research 2021, 13:227-239

Published Date: 1 April 2021

Costs of Biopsy and Complications in Patients with Lung Cancer

Chiu YW, Kao YH, Simoff MJ, Ost DE, Wagner O, Lavin J, Culbertson RA, Smith DG

ClinicoEconomics and Outcomes Research 2021, 13:191-200

Published Date: 17 March 2021

Cost-Utility Analysis of Anterior Vertebral Body Tethering versus Spinal Fusion in Idiopathic Scoliosis from a US Integrated Healthcare Delivery System Perspective

Polly DW, Larson AN, Samdani AF, Rawlinson W, Brechka H, Porteous A, Marsh W, Ditto R

ClinicoEconomics and Outcomes Research 2021, 13:175-190

Published Date: 15 March 2021

Willingness to Pay for Childhood Malaria Vaccine Among Caregivers of Under-Five Children in Northwest Ethiopia

Wagnew Y, Hagos T, Weldegerima B, Debie A

ClinicoEconomics and Outcomes Research 2021, 13:165-174

Published Date: 15 March 2021

The Trend of Direct Medical Cost of Meliodiosis Patients in Kedah: A Retrospective Study from 2014 to 2017

Mardhiah K, Wan-Arfah N, Naing NN, Abu Hassan MR, Chan HK, Hasan H

ClinicoEconomics and Outcomes Research 2021, 13:155-162

Published Date: 11 March 2021

Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database

Matsumoto T, Tsuchiya T, Hirano T, Laurent T, Matsunaga K, Takata J

ClinicoEconomics and Outcomes Research 2021, 13:145-153

Published Date: 25 February 2021

New Perspective to Improve Care of Patients with Infected Diabetic Foot Ulcer: Early Economic Impact of the Use of Photodynamic Therapy with RLP068 (Based) System

Lorenzoni V, Chiavetta A, Curci V, Della Pepa G, Licciardello C, Pantò F, Scatena A, Turchetti G

ClinicoEconomics and Outcomes Research 2021, 13:135-144

Published Date: 26 February 2021

Short and Mid-Term Economic Impact of Pulmonary Artery Catheter Use in Adult Cardiac Surgery: A Hospital and Integrated Health System Perspective

Stevens M, Davis T, Munson SH, Shenoy AV, Gricar BLA, Yapici HO, Shaw AD

ClinicoEconomics and Outcomes Research 2021, 13:109-119

Published Date: 5 February 2021

Catastrophic Health Expenditure among Chronic Patients Attending Dessie Referral Hospital, Northeast Ethiopia

Shumet Y, Mohammed SA, Kahissay MH, Demeke B

ClinicoEconomics and Outcomes Research 2021, 13:99-107

Published Date: 3 February 2021

Inequality and Inequity in Outpatient Care Utilization in Ethiopia: A Decomposition Analysis of Ethiopian National Health Accounts

Kifle H, Merga BT, Dessie Y, Demena M, Fekadu G, Negash B

ClinicoEconomics and Outcomes Research 2021, 13:89-98

Published Date: 2 February 2021

Budget Impact Associated with the Introduction of the Impella 5.0® Mechanical Circulatory Support Device for Cardiogenic Shock in France

Le Guyader A, Pernot M, Delmas C, Roze S, Fau I, Flecher E, Lebreton G

ClinicoEconomics and Outcomes Research 2021, 13:53-63

Published Date: 19 January 2021